Skip to main content
. Author manuscript; available in PMC: 2013 Sep 2.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Mar;62(3):401–408. doi: 10.1002/acr.20107

Table 1.

Demographic and disease characteristics of study participants by ED utilization.

ED utilization
(number of visits)

Variables None
(n=499)
1–2
(n=230)
≥3
(n=78)
P Value
  Percent of total sample 61.7% 28.5% 9.7%
  Percent of total ED visits 0 41.9% 58.%
Demographics
  Age, mean years (SD) 47.6 (13.1) 49.0 (12.5) 44.5 (11.5) 0.028
  Female, % 91.6 91.3 94.9 0.581
  Caucasian, % 74.8 76.1 65.8 0.201
  Married or living with partner, % 63.1 57.4 48.7 0.033
  Education
    Less than high school, % 2.0 3.9 5.1
    High school graduate, % 10.6 14.8 10.3
    Some college, no degree, % 24.6 23.6 41.0
    Associate degree/trade or vocational school 19.4 21.4 21.8 0.009
    College graduate, % 25.3 20.1 10.3
    Master’s/PhD/Professional degree 18.0 16.2 11.5
  Employed, % 54.1 43.0 25.6 <0.001
  Below poverty level, % 9.1 14.0 27.3 <0.001
Disease Characteristics
  Disease duration, mean years (SD) 13.8 (8.9) 13.4 (7.7) 13.8 (8.0) 0.869
  Disease activity (SLAQ), mean score (SD) 10.9 (7.8) 13.6 (7.5) 16.9 (8.8) <0.001
  Flare in last 3 months, % 42.4 51.8 54.5 0.021
  SF-12
    MCS-12, mean score (SD) 49.8 (13.0) 45.7 (13.0) 41.2 (14.5) <0.001
    PCS-12, mean score (SD) 38.0 (6.0) 36.5 (6.8) 36.1 (6.2) 0.002
  Renal involvement, % 15.8 24.5 43.7 <0.001
    Ever been on dialysis, % 6 8 13 0.129
  Lung involvement, % 16.2 23.5 37.3 <0.001
  Pleurisy, % 22.9 32.3 48.1 <0.001
  Pericarditis, % 2.8 6.1 13.2 <0.001
  Hemoptysis, % 3.2 7.0 5.1 0.073
  CESD, mean score (SD) 12.9 (12.0) 16.7 (11.6) 23.7 (16.2) <0.001
  CESD score 16 or higher, % 30.9 45.9 65.4 <0.001
Medication use
  Hydroxychloroquine 56.4 55.2 60.3 0.740
  Any DMARD 29.5 29.1 41.0 0.103
  Corticosteroids 54.2 60.7 73.1 0.004

SD: Standard Deviation; DMARD: Disease Modifying Anti-rheumatic Drug; CESD:Center for Epidemiologic Studies Depression Scale; SF-12: Medical Outcomes Study Short Form-12; MCS-12: Mental Component Summary; PCS Physical Component Summary;